← Back to Search

Vitamin D and fish oil for Benign Breast Disease (VITAL Trial)

N/A
Waitlist Available
Led By Rulla M Tamimi, ScD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights

VITAL Trial Summary

This trial is investigating whether taking daily dietary supplements of vitamin D3 or omega-3 fatty acids reduces the risk of developing cancer, heart disease, and stroke. This ancillary study will examine whether vitamin D effects mammographic breast density, mammographic texture features, and gene expression profiles in breast biopsy tissue.

Eligible Conditions
  • Benign Breast Disease

VITAL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mammographic breast density
Secondary outcome measures
Breast tissue

VITAL Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Vitamin D and fish oilActive Control1 Intervention
Vitamin D3 (cholecalciferol), 2000 IU per day and 840 mg of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid [EPA] and 375 mg of docosahexaenoic acid [DHA])
Group II: Fish oil and vitamin D placeboActive Control1 Intervention
Vitamin D placebo and 840 mg of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid [EPA] and 375 mg of docosahexaenoic acid [DHA])
Group III: Vitamin D and fish oil placeboActive Control1 Intervention
Vitamin D3 (cholecalciferol), 2000 IU per day and fish oil placebo
Group IV: Vitamin D placebo and fish oil placeboPlacebo Group1 Intervention
vitamin D placebo + fish oil placebo

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,622 Previous Clinical Trials
11,464,850 Total Patients Enrolled
2 Trials studying Benign Breast Disease
20,475 Patients Enrolled for Benign Breast Disease
National Cancer Institute (NCI)NIH
13,718 Previous Clinical Trials
40,959,497 Total Patients Enrolled
1 Trials studying Benign Breast Disease
106 Patients Enrolled for Benign Breast Disease
Rulla M Tamimi, ScDPrincipal InvestigatorBrigham and Women's Hospital

Media Library

Vitamin D and fish oil Clinical Trial Eligibility Overview. Trial Name: NCT02239874 — N/A
Benign Breast Disease Research Study Groups: Vitamin D and fish oil, Fish oil and vitamin D placebo, Vitamin D and fish oil placebo, Vitamin D placebo and fish oil placebo
Benign Breast Disease Clinical Trial 2023: Vitamin D and fish oil Highlights & Side Effects. Trial Name: NCT02239874 — N/A
Vitamin D and fish oil 2023 Treatment Timeline for Medical Study. Trial Name: NCT02239874 — N/A
~301 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top